Clinical Trials Browser

Phase 2/3 × Autistic Disorder × 90 days × Clear all

NCT07218575 2026-06-04

Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations

Phase 2/3 Not yet recruiting

Autistic Disorder, Hamartoma Syndrome, Multiple